
Agidap 350mg Injection
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Daptomycin (350mg)
Overview Agidap 350mg Injection
Cephalexin 350mg injection combats bacterial infections. Indicated for serious skin, soft tissue, cardiac, and bloodstream infections, it acts by eliminating the causative bacteria. Primarily used in hospitalized patients with critical illnesses, administration requires healthcare professional oversight; self-administration is prohibited. Dosage and treatment length are determined by your physician based on infection severity; complete the prescribed course for optimal results. Potential side effects, including diarrhea, headache, vertigo, rash, and hypotension, are usually transient and resolve with continued therapy. Report persistent or bothersome side effects to your doctor. Prior to treatment, disclose any antibiotic allergies, liver or kidney dysfunction. Pregnant or lactating individuals should seek medical counsel before use. Regular blood tests monitoring kidney and liver function may be ordered by your physician.
Uses of Agidap 350mg Injection
Life-threatening bacterial illnesses
Major Benefits of Agidap 350mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Agidap 350mg Injection:
- Rash
- Decreased blood pressure
- Headache
- Dizziness
- Breathlessness
- Abnormal liver function tests
- Urinary tract infection
- Diarrhea
- Increased creatine phosphokinase (CPK) level in blood
How to use Agidap 350mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Agidap 350mg Injection works:
Cefixime 350mg Injection is a bactericidal antibiotic that disrupts bacterial cell walls.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Agidap 350mg Injection with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Agidap 350mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Agidap 350mg Injection during lactation is likely safe. Available human data indicate minimal infant risk associated with the medication.
DrivingSAFE
The administration of a 350mg Agidap injection typically has no impact on driving capabilities.
KidneyCAUTION
For individuals with kidney impairment, the administration of Agidap 350mg Injection requires careful consideration. Dosage modification of Agidap 350mg Injection might be necessary. A physician's consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Agidap 350mg Injection in individuals with liver impairment is likely safe. Current evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Agidap 350mg Injection :
Omit a dose of Agidap 350mg Injection? Seek medical advice.
Facts to Know About Agidap 350mg Injection
| Label | Value |
|---|---|
| Chemical Type | Lipopeptides |
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
| Actions | Membrane-active compound |
